Crossmark

A randomized controlled trial investigating the impact of early goal-directed sedation dominated by dexmedetomidine on cerebral oxygen metabolism and inflammatory mediators in patients with severe brain injury

Crossref DOI link: https://doi.org/10.1007/s10072-024-07916-8

Published Online: 2024-12-14

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lu, Shitao

Song, Haiying

Lin, Yuxin

Song, Bo

Lin, Sheng https://orcid.org/0009-0003-2034-2067
Funding

Funding for this research was provided by:

Natural Science Foundation of Yantai (2021YD052)
License Information

Text and Data Mining valid from 2024-12-14

Version of Record valid from 2024-12-14
More Information

Article History

Received: 20 June 2024

Accepted: 28 November 2024

First Online: 14 December 2024

Declarations

:

: This study was conducted with approval from the Clinical Trial Ethics Committee of Yantaishan Hospital (Approval number: N0.2023125). This study was conducted in accordance with the declaration of Helsinki. Written informed consent was obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below